OR
Cardiology - Heart Failure
Let’s explore the evolving landscape of heart failure management with Prof. John J. V. McMurray.
In this video, he shares insights into incretin-based therapies, such as GLP-1 receptor agonists and dual GLP-1/GIP agonists, which have transformed the treatment of type 2 diabetes and obesity while showing promising benefits in heart failure with preserved ejection fraction (HFpEF). Early clinical trials demonstrate improvements in symptoms, quality of life, exercise capacity, and weight loss, with ongoing studies evaluating their impact on long-term cardiovascular outcomes and mortality.
0 Likes
0 Comments
Rhythm – 11th Global Cardiology Conclave 2026 is a leading international cardiology conference that brings together renowned experts, researchers, and healthcare professionals to discuss the latest advancements in cardiovascular medicine. The conclave features scientific sessions, expert lectures, clinical case discussions, and emerging therapies, fostering knowledge exchange and innovation to improve patient care and cardiovascular outcomes.
© 2026 i-rhythm, All Rights Reserved. MSN i-Rhythm does not provide medical advice, diagnosis or treatment.
For unrestricted access to content and a seamless experience,
Complete your profile to help us deliver a more personalized experience.